#UCL Highlights

[malikkabir]

Heartbreaking Champions League exit | Inter Milan - FC Bayern | Highlights

Despite a strong display in Wednesday night’s 2-2 draw away at Inter, Bayern’s Champions League quest is over following a 4-3 aggregate defeat. Harry Kane put Bayern in front after the restart, but Lautaro Martínez and Benjamin Pavard struck for Inter. Eric Dier netted for Munich, who went looking to equalise on aggregate, but the burden of last week’s 2-1 defeat proved too big.

Watch Full Vedio:

[ballsbalb]

i love you silly little devil boy

[formulavroom]

pedrigavi + daddy iñigo renewal up next 🥰

[chuksman57]

Learn Neymar's Sombrero Flick: Best Step-by-Step Guide!

🔥 Master Neymar’s Signature Sombrero Flick in Minutes! 🔥

In this video, we break down Neymar's iconic sombrero flick with a clear step-by-step tutorial that’s perfect for beginners and aspiring footballers. Whether you're training solo or trying to impress on the pitch, this trick will take your skills to the next level!

👉 Don't forget to like, comment, and subscribe for more football skills tutorials, soccer tricks, and freestyle training videos!

#NeymarSkills #FootballTutorial #SombreroFlick #SoccerTricks #LearnFromTheBest

[valentin10]

PARTITA A SUON DI GOL A BARCELLONA ✨ | BARCELLONA 3-3 INTER | HIGHLIGHTS | UCL 24/25⚫🔵🇮🇹 Yamal #FCBINT #BARINT Thuram Di Marco Dumfries Messi Raphinha Ferran Turpin #UEFA #ChampionsLeague #UEFAChampionsLeague #LiguedesChampions

[megaoffer25]

Dodgers win Game 2, but will Shohei Ohtani injury complicate World Series path?

see more

[gaamx]

Old man Messi || imaginary story || #shorts #football

[salsabilahalfizaidanamanullah]

PSG VS NEWCASTLE

Fakta Pertandingan Dapat Dibaca Di Artikel (Baca/Read)

[borussionella]

AHHHHHHH MY HEART

new vs bvb 25.10.23

[huariqueje]

Gaza 'evacuations' by Israel called coerced transfers, violating laws of...

Professor Ralph Wilde of University College London, an international law expert, unequivocally condemned Israel’s Gaza displacement plans as illegal under multiple legal frameworks. Speaking to Al Jazeera, he asserted that Israel’s occupation itself violates Palestinian self-determination rights, rendering all associated actions, including forced transfers, unlawful. The UCL professor detailed how coerced movement within or beyond Gaza constitutes war crimes, crimes against humanity, and genocide, dismissing Israel’s "voluntary evacuation" claims as fiction amid bombardment. He stressed that even proposed "humanitarian zones" in Rafah would be forced displacement, as Palestinians face Israel-made conditions eliminating genuine choice. Wilde highlighted individual criminal liability for officials and soldiers, noting the International Court of Justice’s jurisdiction over such violations. 

[wusialaupdates]

05.03.25 FCBB04 UCL Round of 16

well finally Bayern managed to win against Xabi Alonsos Leverkusen. Highlight of today's Match is of course Jamals goal ('54)! Flo did not do that great today (as usual against Bayern) and was subbed off early. he was not too happy about that as you can see in his reaction lol

[chuksman57]

The Best Funny Mbappe Moments Soccer Fans Can’t Forget

[covid-safer-hotties]

New COVID Variant XEC May Outpace Others This Fall - Published Sept 18, 2024

"The virus is always going to be mutating away from what it was in order to get more efficient at infecting individuals," Adalja said. "So I think this really highlights the fact that a universal COVID vaccine, or some vaccine with different technologies, perhaps a nasal vaccine and using mucosal immunity, all of those things are important."

What if, get this, we prevented covid cases by improving ventilation, mandating air filtration, and wearing masks in public? Wouldn't that accomplish the same goal right now? Every mutation takes us further away from the current scientific fantasy of a universal covid vaccine. We have to stop cases to make this dream a reality.

by Sophie Putka

The new COVID-19 variant XEC may overtake others in circulation to become dominant in the coming months, experts said, but will not prompt a meaningful change in symptoms or vaccine response.

So far, the CDC's variant proportions tracker has not registered enough cases of XEC in the U.S. to report it. (The agency's projected estimates for the 2 weeks ending in September 14 currently show KP.3.1.1 and KP.2.3 as the leading variants, with 52.7% and 12.2% of national cases, respectively.) Another estimate using data from the variant tracker GISAID has XEC at 1.11% of U.S. cases as of September 15, with around 48 sequences reported.

First detected in Germany in June, it's been found mostly in Central Europe, representing 10% of cases, according to the U.K.'s Science Media Centre.

"XEC represents a fairly minor evolution relative to the SARS-CoV-2 diversity currently in circulation, and is not a highly derived novel variant such as those that were granted Greek letters," like Alpha, Delta, and Omicron, Francois Balloux, PhD, a computational biologist at University College London and director of the UCL Genetics Institute, said in a Science Media Centre statement.

Experts noted that while XEC may have a small advantage in transmission, available vaccines are still likely to provide protection from serious illness.

XEC is a "recombinant variant of some of the other Omicron lineages that have been around for a while, and it does appear to be more immune evasive, giving it a transmissibility advantage in the population with the immunity that it has," Amesh Adalja, MD, of the Johns Hopkins Center for Health Security in Baltimore, told MedPage Today. "But it doesn't really change anything, just like the last variant didn't change anything, or the one before that, one before that, or the one before that."

Currently available COVID vaccines target slightly different subvariants. The updated mRNA shots aimed at KP.2 from Pfizer-BioNTech (Comirnaty) and Moderna (Spikevax), as well as Novavax's vaccine targeting the JN.1 variant lineage, are still protective against the most serious consequences of COVID infections, experts said.

"If this becomes a dominant variant, it will decrease the efficacy against infection of the updated vaccines, but the updated vaccines will still be durable against severe disease [and] hospitalization, and that's what is really the primary function of our current, first-generation COVID vaccines," Adalja said.

Still, he emphasized, the rapid mutation of the virus underscores a need for a different kind of vaccine than those currently available if the goal is to protect against infection rather than just severe disease.

"The virus is always going to be mutating away from what it was in order to get more efficient at infecting individuals," Adalja said. "So I think this really highlights the fact that a universal COVID vaccine, or some vaccine with different technologies, perhaps a nasal vaccine and using mucosal immunity, all of those things are important."

[camav1nga]

Stade Brestois v REAL MADRID highlights | UCL group stage final matchday | January 29th, 2025

[marcusrashforddefender]

good morning unitedblr i’m perpetually rewatching last night’s highlights and i will probably tell my future children about this game the same way my father tells me about the ‘99 ucl final

[bpod-bpod]

Crossing the Node

Nerve axons – slender projections, the route of signals from neurons to other cells – are insulated with a sheath called myelin to ensure signals stay on track, however, there are specialised gaps in the wrapping at Nodes of Ranvier which aid signal conduction. This study, using time-lapse microscopy in live mice, investigates how these nodes impact the essential transport of neurons' contents such as mitochondria (highlighted here in cyan) and endosomes (in magenta) along the axons, providing insight into nerve function in health, injury and disease

Read the published research article here

Image from work by Andrew P. Tosolini and colleagues

Department of Neuromuscular Diseases and UCL Queen Square Motor Neuron Disease Centre, Queen Square Institute of Neurology, University College London, UK

Image originally published with a Creative Commons Attribution 4.0 International (CC BY 4.0)

Published in iScience, October 2024

You can also follow BPoD on Instagram, Twitter and Facebook